Dashboard Market News Pricing Contact Us
Search 100,000+ stocks...
English EN
Deutsch DE Español ES
Sign Up
Log in
Transgene SA banner

Transgene SA
LSE:0OCQ

Watchlist Manager
Transgene SA Logo
Transgene SA
LSE:0OCQ
Watchlist
Price: 0.863 EUR 0.12% Market Closed
Market Cap: €310.2k
Write Note Create Alert Ask AI

Wall St Price Targets

0OCQ Price Targets Summary
Transgene SA

Wall Street analysts forecast 0OCQ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 0OCQ is 1.628 EUR with a low forecast of 1.108 EUR and a high forecast of 1.781 EUR.

0OCQ Lowest Forecast
Wall Street Target
€1.108
28% Upside
0OCQ Average Forecast
Wall Street Target
€1.628
89% Upside
0OCQ Highest Forecast
Wall Street Target
€1.781
106% Upside
Lowest Forecast
Price Target
1.108 EUR
28% Upside
Average Forecast
Price Target
1.628 EUR
89% Upside
Highest Forecast
Price Target
1.781 EUR
106% Upside
Transgene SA Competitors:
Price Targets

Revenue
Forecast

-5% / Year
Past Growth
105% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss
-5% / Year
Past Growth
105% / Year
Estimated Growth
Estimates Accuracy
-13%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 105%.

What are analyst estimates?

Gross Profit
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

What are analyst estimates?

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

What are analyst estimates?

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

What are analyst estimates?

Continue 0OCQ Research

Summary
0OCQ intrinsic value, competitors valuation, and company profile.
DCF Valuation
0OCQ stock valuation using Discount Cash Flow valuation method.
Relative Valuation
0OCQ stock valuation using valuation multiples.
Wall St Estimates
0OCQ price targets and financial estimates made by Wall Street analysts.
Profitability
Detailed analysis of the company's profitability.
Solvency
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
0OCQ stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall St Estimates
Profitability
Solvency
Financials
Discount Rate
Other Transgene SA listings:
OTC • USD
TRGNF
 F • EUR
TGNA
 PAR • EUR
TNG
 SWB • EUR
TGNA
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 0OCQ's stock price target?
Price Target
1.628 EUR

According to Wall Street analysts, the average 1-year price target for 0OCQ is 1.628 EUR with a low forecast of 1.108 EUR and a high forecast of 1.781 EUR.

What is the Revenue forecast for Transgene SA?
Projected CAGR
105%

Over the last 14 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 3 years is 105%.

Back to Top
ALPHA SPREAD
Follow us
Join 358,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.